I wouldn't say $15-30B as spare change even for BP but it definitely will be provided Azer-Cel and especially CF33 can expand to other liquid and solid cancer treatments in particular with CF33 combined with CD19 opening up to 90% of the solid cancer market. Highly doubt BP will be offering that much given the risk they can't capture as much of the other cancer treatment market but $6-8B offer is possible.......
IMU Price at posting:
4.1¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)